The upgrade in the price target by a reputable analyst like Calvin Sternick from JP Morgan is a strong positive signal for US Physical Therapy. It suggests a bullish outlook on the company's future performance and financial health, likely leading to increased investor confidence and potentially a rise in stock price in the short term.